AIMOVIG vs MONOPRIL-HCT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 12, 2026·How we rate

Possible drug interaction. AIMOVIG and MONOPRIL-HCT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	MONOPRIL-HCT
Rating	72/100	72/100
Pharmacy pays	—	~$5.05 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
Manufacturer	Amgen Inc	Bristol Myers Squibb
Dosage forms	Injectable, Solution	Tablet
Drug class	—	—
Boxed warning	None	None
Half-life	—	about 6 to 15 hours (the label reports a range, not a single number)

aimovig monopril-hct

Rating

72/100

Pharmacy pays

—

~$5.05 /30

Type

Active ingredient

ERENUMAB-AOOE

FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE

Manufacturer

Amgen Inc

Bristol Myers Squibb

Dosage forms

Injectable, Solution

Tablet

Drug class

—

Boxed warning

None

Half-life

—

about 6 to 15 hours (the label reports a range, not a single number)

Frequently asked questions

Which is better-rated, Aimovig or Monopril-Hct?

Aimovig and Monopril-Hct are tied at 3.6 out of 5 by our independent rating.

What is the difference between Aimovig and Monopril-Hct?

Aimovig contains Erenumab-Aooe, while Monopril-Hct contains Fosinopril Sodium and Hydrochlorothiazide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.